| [1] |
Pratt DS. Liver chemistry and function tests. In: Feldman M, Friedman LS, Brandt LB, editors. Sleisenger and fordtran’s gastrointestinal and liver disease: pathophysiology/diagnosis/management. Philadelphia: Elsevier Saunders, 2016: 1243-1253.
|
| [2] |
Goessling W, Friedman LS. Increased liver chemistry in an asymptomatic patient. Clin Gastroenterol Hepatol, 2005, 3: 852-858.
|
| [3] |
Mayorga CA, Rockey DC. Clinical utility of a standardized electronic order set for the management of acute upper gastrointestinal hemorrhage in patients with cirrhosis. Clin Gastroenterol Hepatol, 2013, 10:1342-1348.
|
| [4] |
Bettigole C. The thousand-dollar Pap smear. N Engl J Med, 2013, 36:1486-1487.
|
| [5] |
Lazo M, Selvin E, Clark JM. Brief communication: clinical implications of short-term variability in liver function test results. Ann Intern Med, 2009, 150:504.
|
| [6] |
Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol, 2003, 98:960-967.
|
| [7] |
Sorbi D, McZGill DB, Thistle JL, et al. Anassessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities. Am J Gastroenterol, 2000, 95: 3206-3210.
|
| [8] |
Tapper EB, Saini S, Sengupta N. Extensive testing or focused testing of patients with elevated liver enzymes. J Hepatol, 2017, 66:313-319.
|
